Rescinnamine
From Self-sufficiency
File:Rescinnamine.svg | |
Systematic (IUPAC) name | |
---|---|
methyl (3β,16β,17α,18β,20α)-11,17-dimethoxy-18-{[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}yohimban-16-carboxylate | |
Clinical data | |
Routes of administration | oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 24815-24-5 |
ATC code | C02AA01 (WHO) |
PubChem | CID 32681 |
DrugBank | APRD00112 |
Synonyms | methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-{[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate |
Chemical data | |
Formula | C35H42N2O9 |
Molar mass | 634.716 g/mol[[Script error: No such module "String".]] |
(verify) |
Rescinnamine is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug.
It is an alkaloid obtained from Rauwolfia serpentina[1] and other species of Rauwolfia.
Brand names
Moderil, Cinnasil, Anaprel
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
40px | This antihypertensive-related article is a stub. You can help ssf by expanding it. |
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- 2Fix
- ACE inhibitors
- Antihypertensive agents
- Phenol ethers
- Cinnamates
- Antihypertensive agent stubs